To request a free sample copy of this report, please complete the form below.
What people say about us!

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

logos logos logos logos logos
Analyst Support
$5,300
BUY NOW
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Ophthalmic Diagnostic Devices Market size was valued at USD 2.41 billion in 2021 and is poised to grow from USD 2.56 billion in 2022 to USD 3.90 billion by 2030, at a CAGR of 6.2% during the forecast period (2023-2030).

The competitive landscape of the ophthalmic diagnostic devices market is characterized by the presence of several key players who offer a wide range of technologically advanced products. These companies strive to develop innovative devices that provide accurate and efficient diagnosis, enabling better patient care. 'Carl Zeiss Meditec AG', 'Topcon Corporation', 'Nidek Co., Ltd.', 'Haag-Streit AG', 'Alcon, Inc.', 'Essilor International S.A.', 'Heidelberg Engineering GmbH', 'Novartis AG', 'Bausch + Lomb Incorporated', 'Johnson & Johnson Vision', 'CooperVision, Inc.', 'Canon Inc.', 'Allergan plc', 'Ziemer Group Holding AG', 'Optovue, Inc.', 'Lumenis Ltd.', 'Leica Microsystems GmbH', 'Hoya Corporation', 'Santen Pharmaceutical Co., Ltd.', 'Oculus Optikgeräte GmbH', 'STAAR Surgical Company', 'Reichert Technologies'

The healthcare expenditure has been steadily increasing, driven by economic growth, expanding health insurance coverage, and government initiatives to improve healthcare infrastructure. This rise in healthcare spending has positively impacted the ophthalmic diagnostic devices market as healthcare facilities and professionals invest in advanced diagnostic equipment to deliver high-quality eye care services.

Ophthalmic diagnostic devices generate a vast amount of data, including imaging data, patient records, and treatment outcomes. The integration of big data analytics allows for efficient storage, analysis, and interpretation of this data, enabling better decision-making, personalized treatment plans, and the development of predictive models for disease progression.

It is expected that North America would hold the largest share of this market, with revenue of USD 907.2 million in 2022. The market for ophthalmic diagnostic devices in the area is anticipated to be driven by high adoption of cutting-edge ophthalmology diagnostic tools, growing awareness of ocular ailments, and rising prevalence of refractive error disorders. Approximately 35.1% of Americans under 50 are myopic, according to a Journal of Current Ophthalmology report. In the upcoming years, it is predicted that the market in this region will grow because of the increased frequency of cataract and myopia.

Feedback From Our Clients

Global Ophthalmic Diagnostic Devices Market

Product ID: SQMIG35A2725

$5,300
BUY NOW